Upgrade to SI Premium - Free Trial

Cytokinetics (CYTK) PT Raised to $118 at Mizuho

June 23, 2026 10:00 AM
Mizuho analyst Salim Syed raised the price target on Cytokinetics (NASDAQ: CYTK) to $118.00 (from $100.00) while maintaining a Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change